NCT05896384View on ClinicalTrials.gov

A Study in Women With Overweight or Obesity to Test Whether Different Doses of BI 456906 Influence the Amount of a Contraceptive in the Blood

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

December 21, 2023

Primary Completion Date

February 14, 2025

Study Completion Date

March 26, 2025

Conditions
Healthy
Interventions
DRUG

BI 456906

BI 456906

DRUG

Microgynon®

Ethinylestradiol (EE) and Levonorgestrel (LNG)

Trial Locations (1)

10117

Charité Research Organisation GmbH, Berlin

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT05896384 - A Study in Women With Overweight or Obesity to Test Whether Different Doses of BI 456906 Influence the Amount of a Contraceptive in the Blood | Biotech Hunter | Biotech Hunter